A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
Clinical trial NCT03456076 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03456076
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2023-06-26
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.